Form 4: Winmark Corp Director Acquires Stock Options
SEC Form 4
Jenele C. Grassle, a director at Winmark Corp, reports the acquisition of stock options.
Summary
- Jenele C. Grassle, a director of Winmark Corp, filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of non-employee stock options on June 1, 2024.
- Grassle acquired 300 non-employee stock options with an exercise price of $355.90, expiring on June 1, 2034.
- The options vest 25% per year over four years, starting June 1, 2025.
- Grassle also directly owns various other non-employee stock options with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of stock options, which can be seen as a positive sign of confidence, but it's not a major event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/01/2016 | Date of non-employee stock option grant with exercise price $91.93, expiring 06/01/2025 |
| 12/14/2016 | Date of non-employee stock option grant with exercise price $90.99, expiring 12/14/2025 |
| 06/01/2017 | Date of non-employee stock option grant with exercise price $98.25, expiring 06/01/2026 |
| 12/12/2017 | Date of non-employee stock option grant with exercise price $125.5, expiring 12/12/2026 |
| 06/01/2018 | Date of non-employee stock option grant with exercise price $122.5, expiring 06/01/2027 |
| 12/11/2018 | Date of non-employee stock option grant with exercise price $134.25, expiring 12/11/2027 |
| 06/01/2019 | Date of non-employee stock option grant with exercise price $143.2, expiring 06/01/2028 |
| 12/11/2019 | Date of non-employee stock option grant with exercise price $156, expiring 12/11/2028 |
| 06/01/2020 | Date of non-employee stock option grant with exercise price $164.84, expiring 06/01/2029 |
| 12/16/2020 | Date of non-employee stock option grant with exercise price $176.2, expiring 12/16/2029 |
| 06/01/2021 | Date of non-employee stock option grant with exercise price $143.87, expiring 06/01/2030 |
| 12/14/2021 | Date of non-employee stock option grant with exercise price $183.87, expiring 12/14/2030 |
| 06/01/2022 | Date of non-employee stock option grant with exercise price $195.82, expiring 06/01/2031 |
| 12/13/2022 | Date of non-employee stock option grant with exercise price $261.32, expiring 12/13/2031 |
| 06/01/2023 | Date of non-employee stock option grant with exercise price $197.8, expiring 06/01/2032 |
| 12/12/2023 | Date of non-employee stock option grant with exercise price $238.6, expiring 12/12/2032 |
| 06/01/2024 | Date of non-employee stock option grant with exercise price $325.99, expiring 06/01/2033 |
| 06/01/2024 | Earliest transaction date; acquisition of 300 stock options at $355.90. |
| 12/01/2024 | Date of non-employee stock option grant with exercise price $446.68, expiring 12/01/2033 |
| 06/01/2025 | First vesting date (25%) for the stock options acquired on 06/01/2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.